Nuvectis Pharma Inc. (NVCT) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Nuvectis Pharma Inc.

    NASDAQ: NVCT · Real-Time Price · USD
    6.00
    -0.07 (-1.15%)
    At close: Oct 03, 2025, 3:59 PM
    6.00
    0.00%
    After-hours: Oct 03, 2025, 04:04 PM EDT

    Nuvectis Pharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 18.53M 19.13M 19.99M 5.74M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a n/a 824K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 74K 59K 412K 91K
    Total Current Assets
    		 18.61M 19.18M 20.41M 5.83M
    Property-Plant & Equipment
    		 n/a n/a n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 n/a n/a n/a 824K
    Total Assets
    		 18.61M 19.18M 20.41M 6.66M
    Account Payables
    		 2.5M 2.77M 2.91M 1.06M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 5.56M 3.8M 450K 824K
    Total Current Liabilities
    		 8.89M 6.98M 6.19M 2.42M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 n/a n/a 2.91M 15.25M
    Total Liabilities
    		 8.89M 6.98M 6.19M 17.66M
    Total Debt
    		 n/a n/a n/a n/a
    Book Value
    		 9.71M 12.2M 14.22M -11.01M
    Book Value Per Share
    		 0.57 0.78 1.12 -0.87
    Common Stock
    		 n/a n/a 14.75B n/a
    Retained Earnings
    		 -73.25M -54.24M -31.98M -12.9M
    Comprehensive Income
    		 n/a n/a -14.75B n/a
    Shareholders Equity
    		 9.71M 12.2M 14.22M -11.01M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist